IFC Holdings’s Immunomedics Inc IMMU Stock Holding History

IFC Holdings’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-40,150	Closed	-$562K	–	550
2017 Q3	$562K	Buy	+40,150	New	+$400K	0.04%	285

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

IFC Holdings's IMMU Position: Q4 2017 in Review

IFC Holdings sold out of Immunomedics Inc (IMMU) in Q4 2017, closing a stake of 40,150 shares — an estimated $562K sold.

IFC Holdings first reported a position in IMMU in Q3 2017 and held it in 1 quarter. The position peaked at $562K in Q3 2017. 157 funds tracked by Wall St. Rank hold IMMU as of Q4 2017.

IFC Holdings reported no remaining Immunomedics Inc position as of Q4 2017 after selling out during the quarter.
IFC Holdings sold 40,150 Immunomedics Inc shares in Q4 2017, an estimated $562K.
IFC Holdings first reported a position in Immunomedics Inc in Q3 2017 and held it in 1 quarter.
IFC Holdings's Immunomedics Inc position peaked at $562K in Q3 2017.
157 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2017.

Based on IFC Holdings's 13F filing for Q4 2017, filed 31 Jan 2018.